November 7, 2011
Ten leading domestic pharmaceutical manufacturers reported a combined 5.3% decrease in sales and 5.7% decline in operating profits in their consolidated semiannual settlements of accounts for 2011. Due mainly to the expiration of patents on major products and the stronger...read more